|
| 37972288 | Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network. | Clin Infect Dis | 2024 |
| 37633258 | Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023. | Clin Infect Dis | 2024 |
| 38066221 | Vaccine Effectiveness Against SARS-CoV-2 Related Hospitalizations in People who had Experienced Homelessness or Incarceration - Findings from the Minnesota EHR Consortium. | J Community Health | 2024 |
| 37988634 | Venous Thromboembolism Among People With HIV: Design, Implementation, and Findings of a Centralized Adjudication System in Clinical Care Sites Across the United States. | J Acquir Immune Defic Syndr | 2024 |
| 36123803 | An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies. | HIV Med | 2023 |
| 37965644 | Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022. | Open Forum Infect Dis | 2023 |
| 38014378 | Early Serial Echocardiographic and Ultrasonographic Findings in Critically Ill Patients With COVID-19. | CHEST Crit Care | 2023 |
| 38011706 | Communicating the Value of Influenza Vaccines to Patients: Translating Vaccine Effectiveness to Acceptance. | Ann Intern Med | 2023 |
| 37590187 | Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 38000964 | Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design. | Vaccine | 2023 |
| 38041853 | Influenza vaccine effectiveness against influenza-A-associated emergency department, urgent care, and hospitalization encounters among U.S. adults, 2022-2023. | J Infect Dis | 2023 |
| 35580849 | Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States. | Clin Infect Dis | 2023 |
| 35776165 | Point Prevalence Estimates of Activity-Limiting Long-term Symptoms Among United States Adults â¿¥1 Month After Reported Severe Acute Respiratory Syndrome Coronavirus 2 Infection, 1 November 2021. | J Infect Dis | 2023 |
| 37394267 | Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023. | Am J Transplant | 2023 |
| 37255285 | Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022. | Clin Infect Dis | 2023 |
| 37120257 | Reduction in COVID-19-related mortality over time but disparities across population subgroups. | Lancet Public Health | 2023 |
| 37333688 | Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort study. | Lancet Reg Health Am | 2023 |
| 37301704 | Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022. | Vaccine | 2023 |
| 37227984 | Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37026401 | Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents. | Pediatrics | 2023 |
| 36921274 | Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022. | MMWR Morb Mortal Wkly Rep | 2023 |
| 36920396 | Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods. | JAMA Netw Open | 2023 |
| 36611252 | Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness. | Clin Infect Dis | 2023 |
| 36683410 | Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network. | J Infect Dis | 2023 |
| 36415904 | Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022. | J Infect Dis | 2023 |
| 36327388 | Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022. | Clin Infect Dis | 2023 |
| 34643241 | Clinical Influenza Testing Practices in Hospitalized Children at United States Medical Centers, 2015-2018. | J Pediatric Infect Dis Soc | 2022 |
| 35675695 | Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. | Clin Infect Dis | 2022 |
| 35347854 | Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. | Influenza Other Respir Viruses | 2022 |
| 35765138 | Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C. | Pediatrics | 2022 |
| 35854999 | Human Herpesvirus-6 Detection in Cerebrospinal Fluid on the BioFire FilmArray Meningitis/Encephalitis Panel in a High Human Immunodeficiency Virus-Prevalence African Setting. | Open Forum Infect Dis | 2022 |
| 35720967 | Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomes. | J Clin Transl Sci | 2022 |
| 35818721 | Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness. | Influenza Other Respir Viruses | 2022 |
| 35862287 | Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35385875 | mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients. | J Infect Dis | 2022 |
| 35353976 | BNT162b2 Protection against the Omicron Variant in Children and Adolescents. | N Engl J Med | 2022 |
| 36695662 | Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022. | Open Forum Infect Dis | 2022 |
| 36580430 | Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36686630 | Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015-2019. | Open Forum Infect Dis | 2022 |
| 36374708 | Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States. | Vaccine | 2022 |
| 36264840 | Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36264830 | Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36220174 | Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. | BMJ | 2022 |
| 36156638 | Long-term Protection Associated With COVID-19 Vaccination and Prior Infection. | JAMA | 2022 |
| 36084198 | Laboratory Evaluation of the VISITECT Advanced Disease Semiquantitative Point-of-Care CD4 Test. | J Acquir Immune Defic Syndr | 2022 |
| 35072082 | Serial Thromboelastography and the Development of Venous Thromboembolism in Critically Ill Patients With COVID-19. | Crit Care Explor | 2022 |
| 35085218 | Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. | MMWR Morb Mortal Wkly Rep | 2022 |
| 34932114 | Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021. | J Infect Dis | 2022 |
| 35264324 | Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. | BMJ | 2022 |
| 35324878 | Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |